Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?

被引：14
|
作者：
Blumenfeld, Zeev [1 ]
机构：
[1] Technion Israel Inst Technol, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 19期
关键词：
INTERNATIONAL CONSENSUS GUIDELINES; STEM-CELL TRANSPLANTATION; BREAST-CANCER PATIENTS; YOUNG-WOMEN; GNRH-AGONIST; CHEMOTHERAPY; GOSERELIN; ONCOLOGY; THERAPY; TRIAL;
D O I：
10.1200/JCO.2018.78.9347
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1895 / +
页数：4
相关论文
共 50 条
  • [41] Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis
    Vitek, Wendy S.
    Shayne, Michelle
    Hoeger, Kathleen
    Han, Yu
    Messing, Susan
    Fung, Chunkit
    FERTILITY AND STERILITY, 2014, 102 (03) : 808 - U525
  • [42] Gonadotropin-releasing hormone agonists: where do we stand?
    Nawroth, Frank
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2019, 17 (02): : 83 - 86
  • [43] Phase II Study of Gonadotropin-Releasing Hormone Analog for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
    Cheng, Yee Chung
    Takagi, Mariko
    Milbourne, Andrea
    Champlin, Richard E.
    Ueno, Naoto T.
    ONCOLOGIST, 2012, 17 (02) : 233 - 238
  • [44] Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist
    Ozcelik, Bulent
    Turkyilmaz, Cagdas
    Ozgun, Mahmut Tuncay
    Serin, Ibrahim Serdar
    Batukan, Cem
    Ozdamar, Saim
    Ozturk, Ahmet
    FERTILITY AND STERILITY, 2010, 93 (05) : 1609 - 1614
  • [45] Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
    Hasky, Noa
    Uri-Belapolsky, Shiri
    Goldberg, Keren
    Miller, Irit
    Grossman, Hadas
    Stemmer, Salomon M.
    Ben-Aharon, Irit
    Shalgi, Ruth
    HUMAN REPRODUCTION, 2015, 30 (05) : 1089 - 1101
  • [46] The LH endocrine profile in gonadotropin-releasing hormone analogue cycles
    Janssens, Lara
    Roelant, Ella
    De Neubourg, Diane
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (10) : 831 - 839
  • [47] Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis
    Li, Zhen-Yu
    Dong, Ying-Li
    Cao, Xiao-Zhong
    Ren, Sha-Sha
    Zhang, Zhen
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2022, 29 (09): : 1093 - 1100
  • [48] Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy
    Blumenfeld, Zeev
    CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13
  • [49] Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females
    Potolog-Nahari, Claris
    Fishman, Ami
    Cohen, Ilan
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (05) : 290 - 294
  • [50] Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
    Merkison, Jamie
    Malcom, Carrie
    Decherney, Alan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345